HOME >> MEDICINE >> NEWS
Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study

HOUSTON - The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.

The risk was first discovered and reported last September by the study's safety monitoring board and led to the shutdown of the colon cancer chemoprevention trial and subsequent withdrawal of the drug from the U.S. market.

The trial, known as APPROVe (Adenomatous Polyp Prevention on Vioxx), was the longest test yet of Vioxx as a chemoprevention agent, and was designed to determine whether the drug could prevent the re-growth of precancerous colon polyps in people who had already had polyps removed. The prospective chemoprevention study randomized 2,586 participants from 108 centers in 29 countries to receive either 25 mgs. of Vioxx daily or a placebo drug for three years, 2001-2004. The trial was stopped September 30, 2004 - approximately two months before its planned completion.

According to Robert S. Bresalier, M.D., of The University of Texas M. D. Anderson Cancer Center and lead author of The New England Journal of Medicine study, 46 of the 1287 patients randomized to take Vioxx daily had confirmed cardiovascular events over a three year period - mostly heart attacks or strokes. In the 1,299 patients given a placebo drug, there were 26 events. Each group, however, had the same number of deaths and not all were related to heart attacks or strokes.

"The overall number of cardiovascular events is small, but, nevertheless, the difference between the groups is significant," says Bresalier, who is professor and chair of the Department of Gastrointestinal Medicine and Nutrition at M. D. Anderson and a member of the study's steering committee.

This study
'"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
15-Feb-2005


Page: 1 2 3

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers offer emergency workers a lifeline
8. Researchers discover genetic variant that may explain why women develop M.S. more than men
9. Researchers map the sexual network of an entire high school
10. Researchers hope monkeys can provide new insights into depression
11. Researchers identify the link between heart failure and weight loss

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... July 17, 2019 , ... Dynamic ... in Medicare Advantage, Medicaid, and Marketplace programs is pleased to announce the introduction ... Health Records (EHR) integration at the point of care to providers and ...
(Date:7/17/2019)... ... July 17, 2019 , ... This past Saturday, Monarch Dental® hosted ... . Over 50 underserved patients were welcomed at the Mesquite office to receive free ... summer season. Individuals were referred to the event through local nonprofit organizations such as ...
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... Women’s Excellence is pleased to announce a ... summer in September. The new offices resides on the corner of Turrill Road and ... We are thrilled about the opening of our new office in Lapeer and the ...
(Date:7/13/2019)... ... July 12, 2019 , ... ... of its proprietary patient management platform, Ospitek “View”. Ospitek has partnered with some ... deliver a fully customizable, intelligent, solution made specifically for surgical centers, allowing them ...
(Date:7/12/2019)... SCOTCH PLAINS, N.J. (PRWEB) , ... July 12, 2019 , ... ... been reviewed and approved by NJ Top Docs for 2019. Located in Paramus, BAXT ... has been providing state-of-the-art cosmetic and medical dermatological care for the past 45 years. ...
Breaking Medicine News(10 mins):
(Date:7/11/2019)... ... July 11, 2019 , ... Voted one of ... and considered by a luminary of the cosmetic world to “represent a revolutionary ... Sciadonic Acid DELTA-5, derived from exotic conifer seeds. DELTA-5 technology works to reduce ...
(Date:7/11/2019)... JERSEY CITY, N.J. (PRWEB) , ... July 11, ... ... at Indiana MGMA , GRM Information Management, a leading provider of enterprise content ... Annual Conference in French Lick, Indiana July 17 to July 19. , ...
(Date:7/11/2019)... ... July 11, 2019 , ... Twenty-one ... among Castle Connolly’s Top Doctors. All of these professionals are recognized as Atlanta’s ... physicians in the publication’s urology category and all of the physicians in the ...
Breaking Medicine Technology:
Cached News: